Previous reports confirmed its proapoptotic activity occurs with the activation of caspase 3 and the cleavage of PARP in preclinical models of leukemia, glioblastoma, or cervical cancer [15,16,17,36], which is similar to our observations. This evidence concerns the gene CASP3 and leukemia.